A Novel CYBB Mutation in Chronic Granulomatous Disease in Iran

Iran J Allergy Asthma Immunol. 2016 Oct;15(5):426-429.

Abstract

Chronic granulomatous disease (CGD) is a rare primary immunodeficiency disorder due to a genetic defect in one of the components of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex. This complex is composed of membrane-bound gp91-phox and p22-phox subunits, and cytosolic subunits consisting of p47-phox, p67-phox, and p40-phox. A mutation in CYBB gene encoding gp91-phox located on chromosome Xp21.1, leads to X-linked CGD. Herein, we report a 4-year-old Iranian boy presented with episodes of recurrent fever, cervical lymphadenopathy, and abdominal abscesses. Mutation analysis of the CYBB gene in the patient indicated a one-nucleotide deletion, c.316delT, resulting in p.W106GfsX.

Keywords: CYBB; Chronic granulomatous disease (CGD); Iran; Mutation; Novel; gp91-phox.

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Chromosomes, Human, Pair 21 / genetics*
  • Granulomatous Disease, Chronic / genetics*
  • Humans
  • Male
  • Membrane Glycoproteins / genetics*
  • Mutation*
  • NADPH Oxidase 2
  • NADPH Oxidases / genetics*

Substances

  • Membrane Glycoproteins
  • CYBB protein, human
  • NADPH Oxidase 2
  • NADPH Oxidases